BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11225414)

  • 1. [MR mammography of response-control in primary chemo-brachytherapy in BCT-inoperable breast cancer].
    Hlawatsch A; Kuner RP; Teifke A; Hoffmann G; Zamboglou N; Thelen M
    Rofo; 2001 Jan; 173(1):31-7. PubMed ID: 11225414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
    Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of metastatic breast cancer response to chemoembolization with contrast agent enhanced and diffusion-weighted MR imaging.
    Buijs M; Kamel IR; Vossen JA; Georgiades CS; Hong K; Geschwind JF
    J Vasc Interv Radiol; 2007 Aug; 18(8):957-63. PubMed ID: 17675611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative assessment of therapy related effects after breast conserving therapy with dynamic MRI of the breast].
    Wersebe A; Xydeas T; Clauss T; Dietz K; Belka C; Fersis N; Claussen CD; Müller-Schimpfle M
    Rofo; 2001 Dec; 173(12):1109-17. PubMed ID: 11740672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
    Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
    Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study.
    Bollet MA; Thibault F; Bouillon K; Meunier M; Sigal-Zafrani B; Savignoni A; Diéras V; Nos C; Salmon R; Fourquet A;
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):13-8. PubMed ID: 17449193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feature extraction and classification of dynamic contrast-enhanced T2*-weighted breast image data.
    Torheim G; Godtliebsen F; Axelson D; Kvistad KA; Haraldseth O; Rinck PA
    IEEE Trans Med Imaging; 2001 Dec; 20(12):1293-301. PubMed ID: 11811829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI and conservative treatment of locally advanced breast cancer.
    Julius T; Kemp SE; Kneeshaw PJ; Chaturvedi A; Drew PJ; Turnbull LW
    Eur J Surg Oncol; 2005 Dec; 31(10):1129-34. PubMed ID: 15905068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
    Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
    Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced MR imaging of the breast in patients with breast implants after cancer surgery.
    Boné B; Aspelin P; Isberg B; Perbeck L; Veress B
    Acta Radiol; 1995 Mar; 36(2):111-6. PubMed ID: 7710787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of MR imaging in the assessment of invasive lobular carcinoma of the breast.
    Mann RM
    Magn Reson Imaging Clin N Am; 2010 May; 18(2):259-76, ix. PubMed ID: 20494311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination therapy of patients with locally advanced breast cancer].
    Manziuk LV; Komov DV; Khaĭlenko VA; Artamonova EV; Mikhina ZP; Ermilova VD; Abashin SIu
    Vopr Onkol; 2001; 47(6):740-3. PubMed ID: 11826501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring breast cancer response to neoadjuvant systemic chemotherapy using parametric contrast-enhanced MRI: a pilot study.
    Chou CP; Wu MT; Chang HT; Lo YS; Pan HB; Degani H; Furman-Haran E
    Acad Radiol; 2007 May; 14(5):561-73. PubMed ID: 17434070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Magnetic Resonance Imaging in the prediction of tumor response in patients with locally advanced breast cancer receiving neoadjuvant chemo-therapy.
    Martincich L; Montemurro F; Cirillo S; Marra V; De Rosa G; Ponzone R; Aglietta M; Regge D
    Radiol Med; 2003; 106(1-2):51-8. PubMed ID: 12951551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications.
    Karlsson YA; Malmström PO; Hatschek T; Fornander TG; Söderberg M; Bengtsson NO; Jansson TE; Sjöberg SM; Bergh JC
    Cancer; 1998 Sep; 83(5):936-47. PubMed ID: 9731898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of preoperative multidetector-row computed tomography in evaluating the extent of invasive lobular carcinoma in patients with or without neoadjuvant chemotherapy.
    Shien T; Akashi-Tanaka S; Yoshida M; Hojo T; Iwamoto E; Miyagawa K; Kinoshita T
    Breast Cancer; 2009; 16(1):30-6. PubMed ID: 18360805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy].
    Sinn HP; Schmid H; Junkermann H; Huober J; Leppien G; Kaufmann M; Bastert G; Otto HF
    Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):552-8. PubMed ID: 8001751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.